chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives; Headache; Muscle pain; Chills; Fever; This spontaneous case was reported by a nurse and describes the occurrence of URTICARIA (Hives), HEADACHE (Headache), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic and Allergy to nuts.    On 04-Mar-2021 at 11:40 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (Fever). On 04-Mar-2021 at 4:00 PM, the patient experienced URTICARIA (Hives) and HEADACHE (Headache). On 05-Mar-2021, URTICARIA (Hives), HEADACHE (Headache) and MYALGIA (Muscle pain) had resolved. At the time of the report, CHILLS (Chills) and PYREXIA (Fever) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered URTICARIA (Hives), HEADACHE (Headache) and MYALGIA (Muscle pain) to be possibly related. No further causality assessments were provided for CHILLS (Chills) and PYREXIA (Fever).    On 04-Mar-2021, the patient took Benadryl 50 mg per oral at 16:00 and again at 20:00. On 05-Mar-2021 at 07:35, the patient reported the hives were almost gone.   Most recent FOLLOW-UP information incorporated above includes: On 05-Mar-2021: VAERS
Ecchymosis noted on injection site, left deltoid & advised mom to apply cold compress.
From phone correspondence received at manufacturer on 4/29/02, it was reported that a 4 y.o. male received DTaP and Infanrix and Ipol vax's in the right thigh on 4/23/02. MMR and Hep A vax were also given on 4/23/02 in the left thigh. The PT returned and treated w/antibiotics for very red and swollen right thigh. From add'l info received at manufacturer on 12/2/02, it was reported that Ipol was given IM in the right thigh. DTaP, was given IM in the right thigh. MMR was given SC in the left thigh. Hep A was given IM in the left thigh. The PT fully recovered form this. Case is closed.
18h p shot - N, fever, rigors, diffuse myalgias, continuing through office visit c L Brone 26h later.
Injection of VARIVAX (L) shoulder - 3-10-09 returned 3-12-09 - Erythema 8x8 cm2 Induration 3x3 cm2 Heat
Four hours after vaccination, headache on left side. Next morning, pain was so intense, couldn't stand up. Still has light lingering headache
No adverse event; expired vaccine/Moderna COVID-19 vaccines by injection on 10NOV2022 (expiration date listed as 20MAY2022); This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine/Moderna COVID-19 vaccines by injection on 10NOV2022 (expiration date listed as 20MAY2022)) and NO ADVERSE EVENT (No adverse event) in an 85-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 019H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Pfizer COVID-19 vaccine (previous dose). Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine.    On 10-Nov-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine/Moderna COVID-19 vaccines by injection on 10NOV2022 (expiration date listed as 20MAY2022)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (expired vaccine/Moderna COVID-19 vaccines by injection on 10NOV2022 (expiration date listed as 20MAY2022)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Concomitant medication was not provided. Patient received previous dose of the Pfizer COVID-19 vaccines and has received a dose of the Moderna COVID-19 vaccines by injection. The expiration date listed on patient's vaccination card is before administration date  No reported symptoms.  Treatment information was not provided.   Reporter did not allow further contact
I report all the symptoms, but today 11/07/2021 in the morning at approximately 7:30 am I had a red urine I had never experienced that effect, the symptoms are stronger and they are weakening me, I just want to know what I can do, thank you.
pt recv vax; red raised rash around inject site, swelling, pain, no itching, general malaise x 24 hr;
Janssen COVID 19 Vaccine EUA  Intense headache, nausea, muscle aches for ~24hours
itching all over the body/experienced this after getting the first vaccine and it became worse after receiving the second dose; This is a spontaneous report from a contactable consumer (patient) via the Pfizer sponsored program.   A female patient of an unspecified age received bnt162b2 (BNT162B2), via an unspecified route of administration on 06Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE; and via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE, 2 SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient received the second dose of Covid-19 vaccine already and said she is itching all over the body. She mentioned that she experienced this after getting the first vaccine (06Feb2021) and it became worse after receiving the second dose. She thought that it was not a side effect of the Covid vaccine. The outcome of the event unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
mom stated on 30NOV92 approx 11PM; pt began crying fever 105 taken to ER-condition improved greataly today-sm amount of rash on lt arm; poss form MMR-sm knot & red on lt leg from DTP;
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown ages and genders. The patients' medical history was not reported. On an unknown dates the patients were vaccinated with improperly stored doses of ROTATEQ oral liquid (dosage unknown; lot # M025568 EXP 07-NOV-2017). No adverse event was reported. This is one of several reports from the same reporter. Additional information has been requested.
Extreme Fatigue started at about 2pm the day after the shot. That night got a fever around 102.4. Awoke this morning with a headache.  Arm is still sore.
Pt developed intense pain in left shoulder within an hour of getting vaccine, unable to lift arm, had redness and swelling in upper arm.
Information has been received from a physician concerning a 56 year old female with no known drug allergies and no pertinent medical history reported, who about 1 month ago, (approximately July 2008) was vaccinated with ZOSTAVAX vaccine(Oka/Merck). On 01-AUG-2008, the patient developed herpes zoster and had about 5 blisters on her right eyelid and forehead. The patient sought medical attention at the office. The patient has not recovered at the time of reporting. Additional information has been requested.
For 2 days after vaccine occasionally felt dizzy with fluttering heart. On and off. Then subsided A week after got hot flashes. Then sucsided During the second week I had an episode when I felt like fainting, Throughout the week I am increasingly tired to a level of total exhaustion and bewilderment. I have extreme reservations about taking the second shot as I never felt so extremely exhausted
VACCINE WAS DRAWN UP THE DAY BEFORE AND WAS GIVEN AT THE 15 HOUR MARK. PATIENT DENIES ANY ADVERSE REACTIONS
10/22/07 - received influenza vaccine 11/19/07 - presented with right shoulder pain and weakness for 24 hours
red and puffy lips; facial flushing; red and puffy lips; swollen tongue; rash; hives around mouth and back; Information has been received from a medical assistant, referring to a 3 years old male patient. The patient had no drug reaction or allergies. Information of concurrent condition and concomitant therapy was unknown by reporter.    On an unknown date, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (dose, strength, route, lot# and expiration date were unknown) for prophylaxis.  On the same day, the patient was also administered an unspecified hepatitis a virus vaccine (manufacturer GlaxoSmithKline) and pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) (manufacturer Pfizer) (indication, dose, frequency, strength, route, lot# and expiration date were unknown).   In March 2017 (reported as around March 2017, after administration of with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB)), the patient developed red and puffy lips, swollen tongue, facial flushing, rash, and hives around mouth and back. All the events were not cancer. The outcome of all events was recovered. The relationship between haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) and all of the events was not reported.
pain in left arm; running down arm; pain is 10 on pain scale; hard to lift the arm let alone lay on it.; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left arm; running down arm; pain is 10 on pain scale) and JOINT RANGE OF MOTION DECREASED (hard to lift the arm let alone lay on it.) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in left arm; running down arm; pain is 10 on pain scale) and JOINT RANGE OF MOTION DECREASED (hard to lift the arm let alone lay on it.). At the time of the report, PAIN IN EXTREMITY (pain in left arm; running down arm; pain is 10 on pain scale) and JOINT RANGE OF MOTION DECREASED (hard to lift the arm let alone lay on it.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. No treatment medications were reported.
Confusion, Myalgia, Fever, CHILLS, SHIVERING Narrative:  MISSED 3 DAYS OF WORK DUE TO XYMPTPOMS
Patient experience a brief moment lightheadedness while waiting in the waiting area after the shot was administered.  He appeared to faint briefly dropping his phone, and almost immediately regained coherence.  Patient sad he felt fine.  2 or 3 minutes later he asked for a cup of water.  He appeared pale at the time but a few minutes later looked normal.   He was anxious about the vaccine.  We were about to call the ambulance and he refused to let us saying he was fine.  He expressed that he didn't want any medical attention.   He also reported after the event, that he hadn't slept the night before or eaten anything that day.  We would not let him drive himself home.  He had his brother pick him up.  We explained what had happened, and will follow up with him to see how the patient is.
had a stiff neck and stiff back; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (had a stiff neck and stiff back) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.    Co-suspect product included non-company product IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.    Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (received 2 regular), PFIZER BIONTECH COVID-19 VACCINE (and a booster dose of the pfizer vaccines) and PFIZER BIONTECH COVID-19 VACCINE (received 2 regular). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.   On 15-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient started IBUPROFEN (ADVIL [IBUPROFEN]) (unknown route) at an unspecified dose. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (had a stiff neck and stiff back). At the time of the report, MUSCULOSKELETAL STIFFNESS (had a stiff neck and stiff back) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   The patient had not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient got the booster shot last Sunday 15JAN2022. Patient had previously gotten pfizer shots Dec 2021.  Patient got dose in left arm and the next day had a stiff neck and stiff back.  First three days,  were really bad.  It was now 8 days later.  She had neck on the right side it had not subsided yet. She had rested her neck like she would do with a tightness, but it has not gone away. Patient was been taking advil. No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 26-Jan-2023: Follow-up received include no new information.
Came down with shingles - 30 days hospital turned into heart attack - 30 more days hospital body rash all over - still under treatment 7 months now. Very painful and bleeding. 3/21/08-records received for DOS 8/17-8/19/07-DC DX: herpetic shingles on left lower leg and also on bilateral thighs. Possible allergic reaction to the patient taking herpes zoster vaccine. C/O chest pain and rash. Vaccine administered 2 weeks ago. Burning sensation along chest and lower left leg. Did not feel well and generalized weakness. Presented to ER with burning chest pain, rash all over chest. C/O itchiness and redness.
body aches the next day; tiredness; This non-serious case was reported by a consumer via call center representative and described the occurrence of general body pain in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of fatigue (1st dose received on 23rd March 2021, refer case US2023109506).   On 18-JUN-2021, the patient received the 2nd dose of Shingrix. On 19-JUN-2021, 1 days after receiving Shingrix, the patient experienced general body pain (Verbatim: body aches the next day) and tiredness (Verbatim: tiredness). Rechallenge with Shingrix was positive. The outcome of the general body pain and tiredness were resolved (duration 24 hrs).   It was unknown if the reporter considered the general body pain and tiredness to be related to Shingrix.     It was unknown if the company considered the general body pain and tiredness to be related to Shingrix.   Linked case(s) involving the same patient:  US2023109506   Additional Information: GSK Receipt date: 11-AUG-2023 The reporter was the wife of the patient. After the patient received the second dose, the patient experienced the same events, tiredness and body aches the next day which lasted for 24 hours. The reporter consented to follow up.
No adverse event; Customer reported expired PNEUMOVAX 23 was administered to a patient who was either 66 or 67 years of age (exact age was unknown to the caller).; This spontaneous report was received from a pharmacist referring to an elderly female patient who was either 66 or 67 years old. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent condition, and concomitant drugs were not reported.   On 17-DEC-2022, the patient was vaccinated with a dose of expired Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection (lot#: T040202, expiration date: 11-SEP-2022, product qunatity: 1; strength, dose, route of administration, and anatomical location were not reported) (expired product administered). No additional adverse event reported.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypertension-Severe, Systemic: Tachycardia-Severe
Just weeks after the flu vaccine my son started to swell until he had gained several pounds in a matter of days. His face, belly and eyelids swelled and he had 2 ER visits in 2 days. He had developed Sudden Onset Nephrotic Syndrome. I was informed By the Nephrotic Specialist it could have been a reaction to the flu shot but we may never know after I was concerned the timing was conspicuously soon after the shot.
Bleeding when needle taken out. Developed large hard lump immediately after. Applied ice to site. Later in day, developed a red raised rash all around site - took BENADRYL. Large dark bruise remains. Rash resolved.
Information has been received from a physician for the pregnancy registry for GARDASIL, concerning a 24 year old female patient with no known drug allergies, who on 26-APR-2008 was vaccinated with her first dose of GARDASIL (lot# 654272/0073X). There was no concomitant medication. On 08-APR-2008 the patient had her LMP and in MAY-2008 (6 weeks from her LMP), the patient had an elective termination. At the time of reporting the outcome of the patient was unknown. Subsequently, the patient again experienced vaccine exposure during pregnancy and an elective termination of pregnancy while on therapy with GARDASIL (MSD, WAES_0903USA04267). Upon internal review elective termination was considered as an Other Important Medical Event. Additional information has been requested.
Information has been received from a registered pharmacist concerning a male, approximately 5 months of age, who on 05-SEP-2002 and 15-NOV-2002 was vaccinated with doses of Recombivax HB (lot# 642924/0304M and 644060/0782M, respectively). The second dose was considered to be an inappropriate schedule of vaccine administration. Subsequently, the patient experienced an allergic reaction post vaccination. No outcome information was reported. No product quality complaint was involved. Additional information was not provided.
nausea & vomiting 1-2 hrs p/2nd dose of vax;
Meltdowns, tantrums, violence, inability to regulate emotions for days, suicidal and homicidal.
per grandma pt healthy until p/vax 7JUL94 became ill evening 9JUL94 lethargic AM 10JUl94 dry diaper taken to hosp; dx liver failure; candidate for liver transplant; several days later liver functioning nl; leg bruised from knee to thigh;
Small lump noted at site, minimal redness x 2 days. Gone by 8/30/04: pt feels fine. Stated by parents.
No adverse event; Patient received first dose on 22-JAN-2021 and second dose on 04-MAR-2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 22-JAN-2021 and second dose on 04-MAR-2021) and NO ADVERSE EVENT (No adverse event) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 030L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 22-JAN-2021 and second dose on 04-MAR-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 22-JAN-2021 and second dose on 04-MAR-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received first dose on 22-JAN-2021 and second dose on 04-MAR-2021).    No concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-648567 (Linked Report). This case was linked to MOD-2022-648569 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-648567:MOD22-024255 (Same Reporter)
Numbness in fingers and hands, arms, legs, and feet. Right leg swollen. Knee 3 times the regular size. Throbbing in feet and swollen, stiffness can't hardly bend right knee. Made my neuropathy worse. Head aches more, blurry vision, light sensitive, body aches, backache, coughing.
Information has been received from a 69 year old female with a penicillin and sulfonamide allergy and a history of vomiting who was vaccinated with a second dose of PNEUMOVAX 23.  Concomitant therapy included blood pressure medication.  Subsequently after she was given the vaccine the patient developed "arm, chest, neck, and face" swelling.  Unspecified blood work was performed.  Unspecified medical attention was sought.  Subsequently, the patient recovered "a year and half after the shot".  Additional information has been requested.
8 hours after 2nd pfizer covid vaccination. Fever 101.3 , chest pain with diaphoresis, trended troponins to a nadir of 19.0. EKG changes with ST changes in 3 non-contiguous leads. Initially treated for an NSTEMI with heparin. Transitioned to colchicine and ibuprofen for myocarditis.
PATIENT RECIEVED A SUB-Q DOSE OF ZOSTAVAX IN HER RIGHT ARM ON 2/12/2009. THE PATIENT TOLERATED THE SHOT VERY WELL; NO PAIN, SWELLING, REDNESS OR ITCHING AT THE TIME OF VACCINATION. OVER THE WEEKEND THE PATIENT'S INJECTION SITE BECAME RED AND SWOLLEN AND VERY ITCHY. SHE CALLED THE PHARMACY, SPOKE WITH MYSELF, AND WAS CONCERNED BECAUSE HER HUSBAND DID NOT HAVE SIMILAR SYMPTOMS AFTER GETTING HIS SHOT. I TOLD THE PATIENT THAT THE REACTION IS MOST LIELY JUST FROM GETTING THE SHOT, AND SHE IS MOST LIKELY NOT HAVING AN ALLERGIC REACTION. I TOLD HER TO USE COLD COMPRESSES TO HELP THE SWELLING, AND TO USE HYDROCORTISONE CREAM TO HELP WITH THE ITCHING. I CONTACTED THE PATIENT'S PHYSICIAN, AND HE AGREED WITH OUR COURSE OF ACTION.
Pt received 1st Hep-B vaccine with Thimerosol, 5 days before recall. Developed seizures with no focus of other source of event.60 day follow-up dated 7/10/00 provided additional text. Discharge summary dx: neonatal seizures tx w/phenobarb and Ativan x 2 with relief.
None- vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046C21A and 011J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-395985 (Patient Link).
Swelling/warmth at site, developed into redness up arm and then into facial area.
The next day I was extremely tired, had muscle aches, and headache. I couldn't do anything except lay on the couch for the entire day. The next day I was much better. This was my first SHINGRIX shot. I subsequently had a second SHINGRIXx shot on June 29, 2018 and had the same reaction.